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Summary
Autophagy, an intracellular degradation process
highly conserved from yeast to humans, is viewed
as an important defence mechanism to clear intra-
cellular bacteria. However, recent work has shown
that autophagy may have different roles during dif-
ferent bacterial infections that restrict bacterial
replication (antibacterial autophagy), act in cell
autonomous signalling (non-bacterial autophagy)
or support bacterial replication (pro-bacterial
autophagy). This review will focus on newfound
interactions of autophagy and pathogenic bacteria,
highlighting that, in addition to delivering bacteria
to the lysosome, autophagy responding to bacte-
rial invasion may have a much broader role in
mediating disease outcome.
Introduction
Autophagy is an intracellular process delivering cytoplas-
mic material to the lysosome for degradation. The cellular
events of this ancient and highly conserved process have
been well characterized: cytoplasmic material is enclosed
by an isolation membrane, called a phagophore, which
elongates to form a double-membraned vacuole, called
an autophagosome; the autophagosome fuses with the
lysosome to form an autolysosome and degrade the
enclosed material. In this way, autophagy acts as a
cytoplasmic quality control mechanism, eliminating pro-
tein aggregates, damaged organelles and intracellular
microbes to maintain cellular homeostasis (Levine et al.,
2011; Mizushima and Komatsu, 2011). Autophagy
involves the assembly of 36 autophagy-related (ATG) pro-
teins into complexes that are essential for different steps
of autophagosome formation: the ATG1-UNC-51-like
kinase (ULK) complex triggers autophagy, the class III
phosphatidylinositol 3 (PI3) kinase complex generates
PI3P (an essential lipid component of autophagosomes),
the ATG12–ATG5–ATG16L1 ubiquitin-like conjugation
system mediates formation and elongation of the
autophagosome and the ATG8 ubiquitin-like conjugation
system mediates closure of the phagophore (Mizushima
et al., 2011). Despite identification of the ATG proteins and
complexes, the molecular mechanisms and signalling net-
works controlling autophagosome formation have not yet
been fully defined (Mizushima et al., 2011; Hamai and
Codogno, 2012). Of particular interest is the source
of membrane for autophagosome biogenesis, which
enables a remarkable plasticity in determining the location
and size of autophagosome formation (Tooze and Yoshi-
mori, 2010).
When autophagy was discovered over 50 years ago it
was considered a general, non-selective degradative
pathway activated by nutrient limitation. However, it has
been increasingly recognized that autophagosomes may
also degrade cytosolic material, such as intracellular bac-
teria, in a selective manner. While the exact mechanism of
bacterial recognition by autophagy remains unknown, the
best-characterized process involves ubiquitination (Shaid
et al., 2012). Autophagy receptors, such as p62 (seques-
tosome 1 or SQSTM1), NBR1 (neighbour of BRCA1 gene
1), NDP52 (nuclear dot protein, 52 kDa) and OPTN
(optineurin), are pattern recognition receptors, called
sequestosome 1/p62-like receptors (SLRs), that recog-
nize ubiquitinated substrates and recruit membranes for
autophagosome formation through their interaction with
ATG8 family proteins (Deretic, 2012). Over the past 10
years, autophagy has been viewed as a crucial host cell
response to bacterial invasion by delivering intracellular
pathogens to the lysosome. However, newfound interac-
tions of autophagy and pathogenic bacteria has revealed
that autophagy may have different roles during different
bacterial infections that, in addition to bacterial clearance,
co-ordinate cell autonomous signalling and in some cases
promote bacterial replication. As a result, autophagy can
no longer be viewed as strictly antibacterial, and the
therapeutic potential of autophagy to resolve bacterial
infection remains to be fully defined.
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Interactions of autophagy and pathogenic bacteria
Intracellular pathogens can be uptaken passively by mac-
rophages (e.g. mycobacteria) or can actively invade epi-
thelial cells (e.g. Listeria, Shigella or Salmonella). After
internalization, bacteria are either transiently or defini-
tively localized within an internalization vacuole, called a
phagosome. Some pathogens escape from the phago-
some to the cytosol and avoid destruction in phago-
lysosomes (e.g. Listeria or Shigella), whereas other
pathogens interfere with phagolysosome biogenesis and
form replicative vacuoles (e.g. Salmonella or mycobacte-
ria). Pioneering studies have shown that autophagy can
degrade intracellular pathogens located both in the
cytosol (Ogawa et al., 2005; Yoshikawa et al., 2009) and
inside the phagosome (Gutierrez et al., 2004; Birmingham
et al., 2006). However, it now appears that autophagy has
different roles during different bacterial infections that may
restrict bacterial replication (antibacterial autophagy), act
in cell autonomous signalling (non-bacterial autophagy) or
support bacterial replication (pro-bacterial autophagy)
(Fig. 1). Here I focus on novel autophagy–bacteria inter-
actions to illustrate these alternative outcomes, suggest-
ing that autophagy should be viewed as having a much
broader role in the host response to infection than only
delivering bacteria to the lysosome.
Antibacterial autophagy and pathogen clearance
Studies using Listeria monocytogenes, Shigella flexneri,
Salmonella Typhimurium and Mycobacterium tuberculosis
Fig. 1. Different autophagy pathways triggered by bacterial invasion.
A. Antibacterial autophagy. After entry into host cells, bacteria are localized inside an internalization vacuole. Upon vacuolar disruption,
autophagy may recognize ubiquitination signals and intracellular pathogens located (left) in the cytosol (e.g. L. monocytogenes, S. flexneri, S.
Typhimurium) and (right) inside a damaged internalization vacuole (e.g. M. tuberculosis). In both cases, the enclosed bacterium is delivered
to the lysosome for degradation.
B. Non-bacterial autophagy. Autophagy may be targeted against cellular disturbances arising from the bacterial invasion process, such as
membrane damaged from bacterial entry or vacuolar disruption. (Left) Damaged membrane, and inflammasome components localized to
damaged membrane, may be ubiquitinated and targeted to autophagy. (Right) Damaged membrane can also be recognized for autophagy by
non-ubiquitin signals (e.g. NDP52–galectin 8). In both cases, non-bacterial autophagy may trigger cell autonomous signalling and influence
bacterial replication.
C. Pro-bacterial autophagy. Some internalized bacteria (e.g. S. aureus, B. abortus) may recruit a subset of the autophagy machinery and
create a replicative niche inside an autophagosome-like vacuole. These bacteria subvert the autophagy machinery to avoid degradation in a
lysosomal compartment and support bacterial replication. Ub, ubiquitin; SLR, autophagy receptor (e.g. p62, NDP52); LC3, ATG8 family
proteins.
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have independently highlighted autophagy in the restric-
tion of bacterial replication. A theme emerging from these
studies is that bacteria inadvertently exposed to the host
cytosol are cleared by autophagy, whereas bacteria inten-
tionally accessing the host cytosol for replication have
evolved mechanisms to avoid recognition by autophagy
(Randow and Münz, 2012).
Listeria monocytogenes, a Gram-positive bacterium,
survives intracellularly by escaping from phagosomes
using LLO, a pore-forming cytotoxin (Cossart, 2011). In
the cytosol, Listeria uses its surface-expressed ActA
protein to directly recruit the Arp2/3 complex and form
actin tails for motility (Haglund and Welch, 2011). At the
same time, ActA prevents ubiquitination and the recruit-
ment of autophagy receptors (p62 and NDP52) to Liste-
ria (Yoshikawa et al., 2009; Mostowy et al., 2011). In the
absence of ActA, InlK is a Listeria surface protein (which
is only expressed in vivo) that can recruit the major vault
protein (MVP) and also prevent autophagic recognition
of bacteria (Dortet et al., 2011). These observations
suggest that bacterial surface proteins inhibit recruitment
of the autophagy machinery, or that host proteins
recruited by Listeria disguise bacteria from autophagic
recognition. In either case, ubiquitination and autophagic
clearance of Listeria requires the absence of ActA and
InlK, and benefits from multiple autophagy receptors.
Strikingly, Listeria is recognized by autophagy in the
absence of the actin or septin cytoskeleton (Mostowy
and Cossart, 2012a), suggesting that autophagic degra-
dation of Listeria and Shigella does not strictly require
the same molecular machinery (Mostowy et al., 2010;
2011).
Shigella flexneri is a Gram-negative pathogen that
escapes from its internalization vacuole. Once in the
cytosol, Shigella uses its surface-expressed IcsA protein
to recruit N-WASP and the Arp2/3 complex to form actin
tails for motility (Haglund and Welch, 2011). Autophagy of
Shigella is triggered by ATG5 recognition of IcsA (Ogawa
et al., 2005), and is mediated by TECPR1, a Tectonin
domain-containing protein, which binds to ATG5 and pro-
motes autophagosome–lysosome fusion (Ogawa et al.,
2011; Chen et al., 2012). To restrict bacterial motility and
autophagy escape, septins are guanosine triphosphate
(GTP) binding proteins recruited to sites of IcsA-induced
actin polymerization, and form cage-like structures with
ubiquitinated proteins and autophagy receptors (p62,
NBR1 and NDP52) around actin-polymerizing bacterium
(Mostowy et al., 2010; 2011). Shigella thus provides an
example of a bacteria targeted to autophagosomes via a
combination of ubiquitin-independent (i.e. recognized by
ATG5–TECPR1) and ubiquitinated (i.e. recognized by
autophagy receptors) signals (Fig. 2). As a countermeas-
ure to avoid autophagy, Shigella may express IcsB, a type
III secretion system (T3SS) effector, which competitively
binds IcsA to inhibit ATG5 binding, TECPR1 recruitment
and septin cage formation (Ogawa et al., 2005; 2011;
Mostowy et al., 2010; 2011). Shigella may also express
another T3SS effector, VirA, to counteract antibacterial
autophagy. VirA exhibits GTPase-activating protein (GAP)
activity, and manipulation of Rab1 GTPase function by
VirA mediates suppression of autophagy, contributing to
Shigella intracellular survival (Dong et al., 2012). Taken
together, Shigella clearance by autophagy may benefit
from the absence of IcsB and VirA, and requires ATG5–
TECPR1 binding, multiple autophagy receptors, actin
polymerization and septin assembly.
After internalization into host cells, S. Typhimurium, a
Gram-negative pathogen, mostly resides and replicates
within a modified phagosomal compartment called the
Salmonella-containing vacuole (SCV). However, a frac-
tion of Salmonella can become cytosolic and surrounded
by ubiquitin (Perrin et al., 2004). Autophagy receptors dis-
covered to target ubiquitinated Salmonella to autophagic
degradation include p62 (Zheng et al., 2009), NDP52
(Thurston et al., 2009) and OPTN (Wild et al., 2011). To
efficiently clear Salmonella, OPTN is phosphorylated by
TANK binding kinase 1 (TBK1), an IKK-related kinase
responsible for autophagosome maturation (Wild et al.,
2011). Why multiple autophagy receptors are important
for bacterial autophagy remains unknown. Recent work
has shown that NDP52, unlike p62, directly interacts with
the rarely investigated LC3C (autophagy studies com-
monly use LC3B to represent ATG8 family proteins), and
the selectivity of NDP52 for LC3C is critical for anti-
Salmonella autophagy (von Muhlinen et al., 2012). The
interaction between autophagy receptors and ATG8 family
proteins reveals an unexplored specificity underlying
selective autophagy, and also suggests a hierarchical
recruitment of different ATG8 family proteins (i.e. LC3C is
recruited first by NDP52, followed by the recruitment of
other ATG8 family proteins including LC3B) that may
explain the distinct membrane domains recruited to the
Salmonella autophagosome (Cemma et al., 2011; Wild
et al., 2011; Thurston et al., 2012). In sum, autophagic
restriction of cytosolic, ubiquitinated Salmonella requires
multiple autophagy receptors and the direct interaction of
NDP52 with LC3C. Salmonella may also be targeted to
autophagosomes via ubiquitin-independent signals.
Network analysis has identified TOCA-1 (formin binding
protein 1-like or FNBP1L), a transducer of Cdc42-
dependent actin assembly, as an ATG3-interacting
partner in Salmonella-infected cells (Huett et al., 2009).
Via recruitment of ATG3, and not ubiquitination signals,
TOCA-1 activity promotes autophagosome biogenesis
and mediates anti-Salmonella autophagy. Interestingly, in
the case of Shigella, TOCA-1 is required for efficient
N-WASP-mediated actin tail polymerization (Leung et al.,
2008). Whether or not TOCA-1 is required for Shigella–
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septin cage formation and autophagy, also dependent on
N-WASP activity (Mostowy et al., 2010), has yet to be
tested.
Mycobacterium tuberculosis, the causative agent of
human tuberculosis, is a vacuolar pathogen that survives
within macrophages by arresting phagosomal maturation.
A variety of studies have shown that the induction of
autophagy by starvation, inhibition of mTOR (mammalian
target of rapamycin, a suppressor of autophagy), vitamin
D and interferon-gamma (IFNg) may help restrict myco-
bacterial replication (Deretic et al., 2009; Fabri et al.,
2011). p62 appears to be crucial for this process, and
provides mycobacterial autophagolysosomes (phago-
somes surrounded by an LC3-positive double membrane)
with enhanced antimicrobial capacities relative to con-
ventional phagolysosomes (Ponpuak et al., 2010). To
efficiently detect and eliminate mycobacteria, p62 is phos-
phorylated by TBK1 (Pilli et al., 2012), yet how M. tuber-
culosis triggers autophagy from within the phagosome
has been a puzzling issue. Recent work has shown that
membrane permeabilization by the mycobacterial ESX-1
secretion system enables ubiquitin-mediated autophagy
to recognize phagosomal M. tuberculosis (Watson et al.,
2012). Recognition of bacterial DNA by the adaptor
STING (stimulator of interferon genes) is required for
ubiquitination of bacteria, and delivery of ubiquitinated
M. tuberculosis to autophagolysosomes requires p62 and
NDP52. Strikingly, ATG5-deficient mice are highly suscep-
tible to M. tuberculosis infection, highlighting autophagy
as a major determinant of host resistance to M. tubercu-
losis infection in vivo (Castillo et al., 2012; Watson et al.,
2012). These studies have shown that while delivery of M.
tuberculosis to the lysosome may have a direct role in
acute bacterial restriction, autophagy may have additional
roles in overall control by suppressing bacterial growth
and by preventing excessive inflammation.
Fig. 2. The Shigella paradigm. Several autophagy pathways are recruited to S. flexneri, and autophagy (using non-mutually exclusive and
parallel recognition events) may have different roles during Shigella infection. It will be important to identify unique markers for the different
autophagy pathways triggered by Shigella, and to define their specific roles in pathogen clearance.
A. EM image showing LC3-positive, double membrane surrounding cytosolic Shigella (Ogawa et al., 2005).
B. TECPR1 (red) binds to ATG5 and localizes with LC3 (green) around cytosolic Shigella in the absence of ubiquitin (Ogawa et al., 2011).
C. The septin cage (SEPT2, red) entraps cytosolic Shigella and targets bacteria to autophagy (LC3, green) (Mostowy et al., 2010).
D. Recruitment of the septin cage (SEPT2, red) to cytosolic Shigella is interdependent with recruitment of ubiquitin and autophagy receptors
(p62, green) (Mostowy et al., 2010).
E. NOD proteins (NOD2, green) and ATG16L1 (red) are recruited to the Shigella entry site and promote autophagy (Travassos et al., 2010).
F. Galectin 3 (red), a marker for damaged membrane, localizes with autophagy receptors [p62 (here in cyan), NBR1 and NDP52] and LC3
(green) around Shigella (Dupont et al., 2009; Ligeon et al., 2011).
G. Galectin 8 (green), a marker for damaged membrane, surrounding Shigella may recruit NDP52 in the absence of ubiquitin (Thurston et al.,
2012).
H. Membrane damage, labelled by NDP52 (green), around cytosolic Shigella causes intracellular amino acid starvation (Tattoli et al., 2012).
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Non-bacterial autophagy and cell autonomous
responses to bacterial invasion
Whereas autophagic delivery of bacteria to the lysosome
can have a direct role in bacterial restriction, autophagy
may also control infection via regulation of cell autono-
mous immune responses. In this case, work has shown
that autophagic recognition of bacterial invasion is not
targeted against bacteria per se, and is targeted against
cellular disturbances arising from the invasion process,
such as membrane damage. From the examples of Shig-
ella and Salmonella, recognition of bacterial invasion by
non-bacterial autophagy may act in immune signalling
and influence bacterial replication.
Several studies have highlighted a central role for
autophagy in regulating the response to membrane
damaged by invasive bacteria (Fig. 2). Studies using Shig-
ella have shown that NOD proteins (pattern recognition
receptors distinct from SLRs) are recruited with ATG16L1
to the plasma membrane at the site of bacterial entry and
trigger autophagy (Travassos et al., 2010). In the cytosol of
infected cells, membrane remnants induced by invading
Shigella are ubiquitinated and recognized by p62, NBR1
and NDP52 for delivery to autophagosomes (Dupont et al.,
2009; Ligeon et al., 2011). Inflammasome components,
localized to damaged membranes, are also ubiquitinated
and recognized by p62 for autophagy (Shi et al., 2012).
Thus, autophagy accompanies membrane damage and
inflammasome activation to control the immune response
by eliminating membrane and active inflammasomes.
Recent work using Salmonella, and corroborated using
Shigella and Listeria, has revealed that NDP52 can also be
recruited to damaged vacuoles marked by galectin 8, a
cytosolic b-galactoside binding lectin, independently of
ubiquitin (Thurston et al., 2012).Although NDP52–galectin
8 interactions presumably serve to restrict bacterial repli-
cation, they may also help to recruit LC3-positive mem-
brane and repair damaged vacuoles. In agreement with
autophagy playing a role in membrane repair, membrane
fusion has been shown to act as a danger signal that, when
recognized by STING, also triggers cell autonomous
immune responses and cell survival (Holm et al., 2012).
The panoply of events that follow membrane damage
and trigger non-bacterial autophagy is starting to emerge.
The recognition of membrane damage may proceed with
the recruitment of diacylglycerol (DAG), and work using
Salmonella has shown that DAG-dependent signalling
triggers autophagy and contributes to pathogen clearance
(Shahnazari et al., 2010; Cemma and Brumell, 2012).
Host membrane damage by Salmonella and Shigella also
triggers intracellular amino acid starvation, itself a potent
stimulus of autophagy (Tattoli et al., 2012). Indeed,
pathogen-induced amino acid starvation dampens the
activity of mTOR, a serine/threonine protein kinase that
regulates a wide range of cellular responses including
autophagy (Laplante and Sabatini, 2012). Thus, amino
acid starvation is a newfound element of the immune
response to intracellular bacteria.
The precise role of non-bacterial autophagy in the
control of bacterial replication is not fully defined. At least
in the case of Salmonella, non-bacterial autophagy trig-
gered by the p62-mediated recognition of cytosolic, ubiq-
uitinated structures which accompany infection has been
shown to restrict bacterial replication (Mesquita et al.,
2012). However, Salmonella can inhibit the selective
autophagy of ubiquitinated structures by expressing
SseL, a T3SS effector which acts as a deubiquitinase,
and SseL activity lowers autophagic flux and promotes
bacterial replication. This infection scenario is similar
to autophagy triggered by Mycobacterium marinum,
an intracellular pathogen that causes tuberculosis-like
disease in ectotherms. In cells infected with M. marinum,
cytosolic aggregates comprised of host and bacterial
membrane remnants are ubiquitinated and targeted to
autophagy (Collins et al., 2009). However, the role of non-
bacterial autophagy in response to these ubiquitinated
structures in M. marinum replication is not yet known.
Pro-bacterial autophagy and the support of
bacterial replication
Canonical autophagy is dependent on the hierarchical
and co-ordinated recruitment of ATG proteins to the
phagophore, to form and elongate an autophagosome
that will fuse with the lysosome. By contrast, non-
canonical autophagy may not require all of the autophagy
machinery to form autophagosome-like vacuoles, and can
be recognized when a subset of ATG proteins are
recruited to an already-existing membrane (Mostowy and
Cossart, 2012b). A well-characterized example of non-
canonical autophagy is LC3-associated phagocytosis
(LAP), a process in which phagosomes containing bacte-
ria can recruit LC3 to promote phagosome maturation and
degradation of cargo (Sanjuan et al., 2007). However,
new evidence suggests that non-canonical autophagy
can benefit the infection of some pathogens, including
L. monocytogenes, Staphylococcus aureus, Brucella
abortus and uropathogenic Escherichia coli.
While intracellular L. monocytogenes can evade
autophagy in the cytosol via expression of ActA or InlK, a
subpopulation may co-opt autophagy machinery and
slowly replicate inside vacuoles called SLAPs (spacious
Listeria-containing phagosomes) (Birmingham et al.,
2008). SLAP formation occurs via the LAP pathway and
requires dampened activity of LLO to damage membrane
and inhibit fusion with the lysosome (Cemma and Brumell,
2012). In this way, SLAPs may enable chronic bacterial
infection.
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S. aureus is a Gram-positive bacterium that can invade
cells and replicate in autophagosome-like vacuoles
that colocalize with LC3 (Schnaith et al., 2007). Hla
(a-haemolysin), a pore-forming toxin secreted by
S. aureus, is required for the recruitment of LC3, suggest-
ing the recruitment of autophagy components to mem-
brane damage mediated by Hla (Mestre et al., 2010).
Hla-induced autophagy requires ATG5, but does not
require Beclin1 (ATG6) nor PI3 kinase activity, highlighting
the benefit of a non-canonical autophagy pathway for
S. aureus replication.
After entry into host cells, B. abortus, a Gram-negative
intracellular pathogen, establishes a replicative compart-
ment called Brucella-containing vacuoles (BCVs). To
promote infection, Brucella may co-opt autophagosome
initiation factors ATG1 (ULK1), Beclin1 and ATG14 to
convert BCVs into autophagosome-like compartments
called autophagic BCVs (aBCVs) (Starr et al., 2012). A
non-canonical autophagy pathway here promotes bacte-
rial replication and survival since autophagosome elonga-
tion factors ATG4B, ATG5, ATG7, LC3B and ATG16L1 are
not required for biogenesis of aBCVs. Considering recent
evidence showing that Legionella pneumophila, a Gram-
negative intracellular pathogen that may exploit similar
components of the autophagy machinery as Brucella
(Mostowy and Cossart, 2012b), has evolved a mecha-
nism to inhibit autophagy using the type IV secretion
system (T4SS) effector RavZ to irreversibly inactivate
ATG8 (Choy et al., 2012), it is tempting to speculate that
the Brucella T4SS may also co-ordinate aBCV formation.
Whereas evidence that Shigella or Salmonella can
exploit non-canonical autophagy for replication has not
been obtained, recent work has shown that ATG16L1
deficiency confers host protection in vivo against infection
from another Gram-negative pathogen, uropathogenic
Escherichia coli (UPEC) (C. Wang et al., 2012). How
UPEC may co-opt ATG16L and avoid autophagic degra-
dation remains to be fully determined.
Perspectives
There has been much recent progress in understanding
autophagy and how it controls the fate of intracellular
bacteria, highlighting different roles for autophagy during
different bacterial infections. From the examples of Liste-
ria, Shigella, Salmonella and mycobacteria, antibacterial
autophagy may restrict bacterial replication, and non-
bacterial autophagy triggered by membrane damage may
have a critical role in cell autonomous immune responses.
By contrast, from the examples of Staphyloccus, Brucella
and UPEC, some bacterial pathogens may benefit
from pro-bacterial, non-canonical autophagy pathways
that support bacterial replication. These alternative
autophagy–bacteria interactions strongly suggest that
autophagy does more than deliver bacteria to the lyso-
some, and should be recognized for a much broader role
in the response to infection. As a result, more research is
required to clarify the therapeutic potential of autophagy
(Box 1). Understanding these issues may suggest the
development of new strategies aimed at bacterial infec-
tion, and possibly other infectious, autoimmune and
inflammatory disease states that also implicate autophagy
(Levine et al., 2011; Mizushima and Komatsu, 2011;
Rubinsztein et al., 2012).
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Box 1. Critical issues in autophagy–bacteria interactions.
• What is the relative importance of ubiquitin and non-ubiquitin
signals in pathogen clearance? Can the recognition of bacteria
by autophagy be increased/altered to favour bacterial
degradation?
• Components of the cytoskeleton/membrane interface [e.g.
septins, TOCA-1 and vimentin (R.C. Wang et al., 2012)] may be
key mediators of autophagosome formation. Can these compo-
nents be used to enhance recruitment of the autophagy machin-
ery to bacteria?
• SLRs have been specifically implicated in innate immunity, but
may have a more general role in selective autophagy (Gibbings
et al., 2012; Tumbarello et al., 2012). Are there SLRs exclu-
sively dedicated to pathogen clearance?
• Saccharomyces cerevisiae encodes only a single ATG8 gene,
yet humans and other animals encode multiple ATG8 genes
belonging to different subfamilies, i.e. LC3s or GABARAPs.
Does the expansion of ATG8 genes reflect another layer of
specificity underlying bacterial autophagy?
• What is the source of membrane for antibacterial autophagy?
Can the initial sequestering membrane be used to regulate
autophagic activity (e.g. control autophagosome location and
size)?
• Under what circumstance can cytokines (e.g. TNFa, IFNg,
IL-1b) and other physiological stimuli (e.g. rapamycin, amino
acid starvation) be applied to induce autophagic degradation of
bacteria?
• Can non-canonical autophagy pathways be manipulated to
favour bacterial degradation? Forcing aspects of the ATG-
dependent machineries to overcome autophagy blockage (e.g.
targeted delivery of ATG8 family proteins) may transform
non-canonical autophagy into canonical autophagy and
degradation.
• What is the role of human autophagy in infection and other
disease states? It is critical to functionally validate human
genetic studies that implicate the autophagy machinery in infec-
tious, autoimmune and inflammatory disease states, and deter-
mine if these are diseases of canonical autophagy.
• Unlike bacterial effectors that enable evasion of autophagic
recognition (e.g. Listeria ActA and InlK, Shigella IcsB and VirA,
Salmonella SseL), a bacterial effector that targets the auto-
phagy machinery for intracellular survival has recently been
discovered (Choy et al., 2012). What specific mechanisms have
bacterial pathogens evolved to inhibit autophagy?
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